Am J Transplant, Volume 19, Suppl 3 Archives - Page 173 of 214 - ATC Abstracts

2019 American Transplant Congress
Outcomes Of Treatment Of Late Vs Early Acute Antibody-mediated Rejection In Renal Transplant Recipients – A Single Center Experience
R. Prashar, N. Sulejmani, A. Patel
Henry Ford Transplant Institute, Detroit, MI
*Purpose: The diagnostic accuracy and treatment options for acute antibody-mediated rejection (aABMR) in RTRs has improved over the last several years. However,response to treatment in…
2019 American Transplant Congress
Tumor Necrosis as a Result to Pre-Transplant Bridging Treatment for Hepatocellular Carcinoma and Its Effect on Post-Transplant Outcome
S. Radunz¹, A. Kirschner¹, J. M. Theysohn², C. Schotten³, T. Benkö¹
¹General, Visceral and Transplant Surgery, University Hospital Essen, Essen, Germany, ²Diagnostic and Interventional Radiology and Neurradiology, University Hospital Essen, Essen, Germany, ³Gastroenterology and Hepatology, University Hospital Essen, Essen, Germany
*Purpose: As a bridge to liver transplantation, locoregional treatments are commonly employed in hepatocellular carcinoma (HCC) patients to prevent tumor progression during waiting time. Objective…
2019 American Transplant Congress
Early Everolimus Conversion For Renal Protection In Liver Transplantation: The Sooner The Better?
M. Tomeczkowicz, N. Sulejmani, A. Jantz, B. Summers, T. Larson, R. Salgia
Henry Ford Health System, Detroit, MI
*Purpose: Calcineurin inhibitors (CNI) are the mainstay of immunosuppressive therapy in transplantation; however, a major side effect limiting CNI use is nephrotoxicity. Mammalian target of…
2019 American Transplant Congress
Evaluating Allo-Specific CD57⁺ T Cells during Memory and Proliferative Responses
A. Lucander, H. Xu, A. Kirk
Department of Surgery, Duke University, Durham, NC
*Purpose: We have previously identified subsets of CD57+ T cells that are resistant to B7 costimulation blockade (CoB) in kidney transplant recipients. The objective of…
2019 American Transplant Congress
Kidney Transplant Outcomes in Recipients with Physical Impairments
A. G. Thomas¹, J. Ruck², N. Chu², D. Agoons², A. Shaffer², C. Haugen², H. Ying², B. Swenor², S. Norman³, J. Garonzik-Wang², D. Segev², M. McAdams-DeMarco²
¹Epidemiology, UNC Chapel Hill, Chapel Hill, NC, ²Johns Hopkins University, Baltimore, MD, ³University of Michigan, Ann Arbor, MI
*Purpose: Disability in general has been associated with poor outcomes in KT recipients. However, disability can be derived from various components, specifically visual, hearing, physical,…
2019 American Transplant Congress
Gait Speed Predicts Kidney Transplant Candidate Mortality
M. N. Harhay¹, K. Ranganna¹, L. B. Levin Mizrahi¹, G. Xiao², G. Malat², S. Guy², D. Reich², P. P. Reese³
¹Medicine, Drexel University College of Medicine, Philadelphia, PA, ²Surgery, Drexel University College of Medicine, Philadelphia, PA, ³Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA
*Purpose: Waiting list mortality is increasingly scrutinized as a metric of transplant center quality. It is unknown if gait speed assessments may augment physician evaluations…
2019 American Transplant Congress
High Health Care Utilizers in Kidney Transplantation: Do You Know Your Frequent Flyers?
E. Weeda¹, Z. Su², D. Taber³, J. Bian², T. A. Morinelli⁴, N. A. Pilch⁵, P. D. Mauldin², D. A. DuBay⁴
¹Department of Clinical Pharmacy and Outcomes Sciences, Medical University of South Carolina`, Charleston, SC, ²General Internal Medicine and Geriatrics, Medical University of South Carolina`, Charleston, SC, ³Surgery and Ralph H. Johnson VAMC, Medical University of South Carolina`, Charleston, SC, ⁴Surgery, Medical University of South Carolina`, Charleston, SC, ⁵Clinical Pharmacy and Outcomes Sciences, Medical University of South Carolina`, Charleston, SC
*Purpose: To assess high hospital inpatient [IP] admissions and emergency department [ED] utilization within a 9-month period after kidney transplantation in order to identify potential…
2019 American Transplant Congress
Organ Donation Rates And Transplantation Activity Comparing Opt-out Versus Opt-in Systems: A Cross-sectional Study Of Oecd Countries
A. Arshad¹, M. Babiker², B. Anderson², A. Sharif²
¹University of Birmingham, Birmingham, United Kingdom, ²Queen Elizabeth Hospital, Department of Nephrology and Transplantation, Birmingham, United Kingdom
*Purpose: The aim of this study was to compare organ donation and transplantation rates between opt-out versus opt-in countries to investigate for any significant difference…
2019 American Transplant Congress
Multicenter Experience Evaluating Outcomes of HCV-Seropositive Donors to HCV-Seronegative Recipients Liver Transplantation
K. Wijarnpreecha¹, B. Aqel², S. Pungpapong¹, C. Taner³, K. Reddy⁴, M. Leise⁵, R. Dickson²
¹Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, ²Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ, ³Transplant, Mayo Clinic, Jacksonville, FL, ⁴Transplant and Hepatobiliary Surgery, Mayo Clinic, Scottsdale, AZ, ⁵Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN
*Purpose: Grafts from hepatitis C virus (HCV)-seropositive donors can now be considered for liver transplant (LT) due to the advent of direct-acting antiviral agents (DAA).…
2019 American Transplant Congress
CXCL12-CXCR4-Mediated Chemotaxis is a Potential Mechanism for Monocyte Recruitment in Ischemia-Reperfusion Injury in Orthotopic Liver Transplant Patients
A. Q. Terry¹, R. A. Sosa¹, B. V. Naini¹, V. Groysberg¹, F. M. Kaldas², R. W. Busuttil², D. Gjertson¹, J. Kupiec-Weglinski², E. F. Reed¹
¹Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA, ²Surgery, University of California, Los Angeles, Los Angeles, CA
*Purpose: Ischemia-reperfusion injury (IRI) elicits cellular damage which lowers allograft survival in orthotopic liver transplant (OLT) patients. Damage-associated molecular patterns, such as high-mobility group box…